Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Arf and Ink4a Are Critical Factors Determining the Cell of Origin and Therapeutic Sensitivity in Myc-Induced Mouse Lymphoid Tumor

Eiji Sugihara, PhD, Takatsune Shimizu, MD, PhD, Kensuke Kojima, MD, PhD, Jo Ishizawa, MD, PhD, Michael Andreeff, M.D., Ph.D., Hideyuki Saya, MD, PhD

Blood (2011) 118 (21): 2448.

https://doi.org/10.1182/blood.V118.21.2448.2448

Published: 2011

Journal Articles

A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.

Morihiko Sagawa, MD, Takatsune Shimizu, MD, Mingji Xian, MD, Aki Chizuka, MD, Naoshi Fukushima, PhD, Yasuko Kinoshita, PhD, Iwao Ohizumi, PhD, Yasuo Ikeda, MD, Hisafumi Okabe, PhD, Masahiro Kizaki, MD

Blood (2006) 108 (11): 2097.

https://doi.org/10.1182/blood.V108.11.2097.2097

Published: 2006

Journal Articles

Shikonin Induces Apoptosis by Inhibiting Phosphorylation of IGF-1 Receptor in Myeloma Cells.

Takehiro Kimura, MD, Tomonori Nakazato, MD, Takatsune Shimizu, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 4858.

https://doi.org/10.1182/blood.V104.11.4858.4858

Published: 2004

Journal Articles

Novel Human Monoclonal Antibody Against CD47 Induces Cell Death in Lymphoid Malignant Cells In Vitro and In Vivo : Potential Novel Therapeutic Agent for B-CLL.

Takatsune Shimizu, MD, Yoshitaka Miyakawa, MD, Naoshi Fukushima, PhD, Yasufumi Kikuchi, PhD, Shigeyuki Iijima, PhD, Yasuko Kinoshita, PhD, Yumiko Azuma, PhD, Iwao Ohizumi, PhD, Hisafumi Okabe, PhD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 2511.

https://doi.org/10.1182/blood.V104.11.2511.2511

Published: 2004

Journal Articles

A Novel Mechanism for Imatinib Mesylate (STI571) Resistance in CML Cells: Contribution of TC-PTP to Modulating Signals Down-Stream from the BCR-ABL Fusion Protein.

Takatsune Shimizu, MD, Yoshitaka Miyakawa, MD, Satoshi Iwata, MD, Akiko Kuribara, BS, Tony Tiganis, PhD, Chikao Morimoto, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 1984.

https://doi.org/10.1182/blood.V104.11.1984.1984

Published: 2004

NARROW

Arf and Ink4a Are Critical Factors Determining the Cell of Origin and Therapeutic Sensitivity in Myc-Induced Mouse Lymphoid Tumor

A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.

Shikonin Induces Apoptosis by Inhibiting Phosphorylation of IGF-1 Receptor in Myeloma Cells.

Novel Human Monoclonal Antibody Against CD47 Induces Cell Death in Lymphoid Malignant Cells In Vitro and In Vivo : Potential Novel Therapeutic Agent for B-CLL.

A Novel Mechanism for Imatinib Mesylate (STI571) Resistance in CML Cells: Contribution of TC-PTP to Modulating Signals Down-Stream from the BCR-ABL Fusion Protein.

Email alerts

ASH Publications

American Society of Hematology

Arf and Ink4a Are Critical Factors Determining the Cell of Origin and Therapeutic Sensitivity in Myc-Induced Mouse Lymphoid Tumor

A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.

Shikonin Induces Apoptosis by Inhibiting Phosphorylation of IGF-1 Receptor in Myeloma Cells.

Novel Human Monoclonal Antibody Against CD47 Induces Cell Death in Lymphoid Malignant Cells In Vitro and In Vivo : Potential Novel Therapeutic Agent for B-CLL.

A Novel Mechanism for Imatinib Mesylate (STI571) Resistance in CML Cells: Contribution of TC-PTP to Modulating Signals Down-Stream from the BCR-ABL Fusion Protein.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only